Education
About Us
Working with TipRanks
Follow Us
Corcept Therapeutics (CH:HTD)
:HTD
Earnings Data
Report Date
Feb 18, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.27Last Year’s EPS
0.21Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Q3 2025
Earnings Call Date:Nov 04, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and a robust pipeline, particularly in hypercortisolism and oncology. However, challenges such as a significant decline in net income and unresolved patent litigation present concerns.Company Guidance
Revenue Growth
Corcept reported Q3 2025 revenue of $207.6 million, up from $182.5 million in the same period last year, representing a 13.8% increase.
Hypercortisolism Business Expansion
The hypercortisolism segment saw a 42.5% increase in tablets shipped compared to Q3 2024, driven by record prescriptions for Korlym.
Pharmacy Transition to Meet Demand
Corcept is transitioning to a new pharmacy with greater capacity and plans to add additional pharmacies, indicating strong demand and anticipated growth.
Pipeline Advancements
Two upcoming PDUFA dates for relacorilant: December 30, 2025 for hypercortisolism and July 11, 2026 for platinum-resistant ovarian cancer, highlighting pipeline progress.
Oncology Program Expansion
Plans to start multiple oncology studies including new trials in gynecological cancers and pancreatic cancer, showing significant commitment to expanding their oncology portfolio.
CH:HTD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
FAQ
When does Corcept Therapeutics (CH:HTD) report earnings?
Corcept Therapeutics (CH:HTD) is schdueled to report earning on Feb 18, 2026, TBA (Confirmed).
What is Corcept Therapeutics (CH:HTD) earnings time?
Corcept Therapeutics (CH:HTD) earnings time is at Feb 18, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Corcept Therapeutics stock?
The P/E ratio of Corcept Therapeutics is N/A.
What is CH:HTD EPS forecast?
CH:HTD EPS forecast for the fiscal quarter 2025 (Q4) is 0.27.